行情

CERS

CERS

Cerus Corp
NASDAQ

实时行情|Nasdaq Last Sale

4.280
+0.190
+4.65%
盘前: 4.440 +0.16 +3.74% 08:41 11/13 EST
开盘
4.050
昨收
4.090
最高
4.360
最低
4.050
成交量
134.88万
成交额
--
52周最高
6.88
52周最低
3.950
市值
6.08亿
市盈率(TTM)
-8.3807
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CERS 新闻

  • BTIG Research Upgrades Cerus to Buy
  • Benzinga.1小时前
  • 沪指低开震荡 纳指再创新高、期金连跌四日
  • 新浪财经.5小时前
  • 同样搞流媒体 迪斯尼服务器被挤爆苹果却“糊”了
  • 新浪财经综合.6小时前
  • 马化腾的科技之战
  • 创事记.6小时前

更多

所属板块

医疗设备、用品及经销
+0.68%
医疗设备和用品
+0.81%

热门股票

名称
价格
涨跌幅

CERS 简况

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.
展开

Webull提供Cerus Corporation的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。